The government is now operating in accordance with the Guidance on Caretaker Conventions, pending the outcome of the 2025 federal election.
Notice for mecasermin (Ipsen Pty Ltd)
Active ingredients
mecasermin
Sponsor
Date of review outcome
Lapse date
Type
Orphan drug
Dosage form(s)
Injection, solution
Indication
Mecasermin is indicated for the long-term treatment of growth failure in children and adolescents with severe primary insulin-like growth factor-1 deficiency (severe primary IGFD).
Therapeutic area
Endocrinology